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Objectives: In response to injury, aging mediates exaggerated neointimal formation, the pathologic hallmark of obliter-
ative vascular diseases. We assessed the development of neointima in a model of mechanical vascular injury in aging mice
(18 months old) and young mice (2 months old). To investigate the mechanisms by which aging affects neointimal
formation, we also carried out a set of in vitro studies to characterize the biologic properties of vascular smooth muscle
cells (VSMCs) derived from aging and young mice.
Methods: Aging and young mice were subjected to wire injury to the carotid artery. Four weeks later injured arteries were
harvested, and neointimal formation was histologically assessed. The profiles of angiogenesis-related genes between aortic
VSMCs derived from aging and young mice were compared with complementary DNA arrays. Expression of platelet-derived
growth factor receptor- (PDGFR-) and proliferation in response to platelet-derived growth factor-BB (PDGF-BB) by
VSMCs were assessed. Susceptibility to apoptosis in aging and young VSMCs in response to nitric oxide and serum starvation
was investigated. In addition, the level of apoptosis in neointimal VSMCs (by terminal deoxynucleotidyl transferase–mediated
deoxyuridine triphosphate nick-end labeling assay) was compared between aging and young animals.
Results: When compared with young mice, aging mice exhibited exaggerated neointimal formation (intima-media ratio,
1.17  0.57 vs 0.49  0.16; P < .0001). Aging VSMCs expressed higher levels of PDGFR- (12.0%  2.7% vs 3.2 
0.67%; P  .034) and greater proliferative response (4-fold increase) to PDGF-BB, compared with young VSMCs.
However, aging VSMCs were less susceptible to apoptosis when subjected to serum starvation (75% less) and exposure to
nitric oxide (50% less). Furthermore, there was more apoptosis in the neointima of young arteries than in their aging
counterparts (8.75%  3.3% vs 2.8%  1.9; P  .021).
Conclusions: Age-dependent increases in PDGFR- may alter VSMC proliferation, and when coupled with resistance to
apoptosis could contribute to exaggerated neointima formation in aging animals. Of significance, our findings in the
mouse will enable application of abundant molecular tools afforded by this species to further dissect the mechanisms of
exaggerated neointimal formation associated with aging. (J Vasc Surg 2004;40:1199-1207.)
Clinical Relevance: Neointimal formation is the pathologic hallmark of obliterative vascular diseases, including primary
atherosclerosis, post stent restenosis, graft occlusion after vascular bypass procedures, and transplant allograft vasculopa-
thy. Aging is an independent risk factor for development of cardiovascular diseases, and aging exaggerates neointimal
formation after vascular injury. Understanding the mechanisms responsible for this phenomenon may facilitate preven-
tion or provide new therapies for vascular occlusive diseases, which are so prevalent in the aging population. Our ability
to reproduce the model in the mouse will no doubt facilitate such understanding.Epidemiologic studies have shown that aging is an
independent risk factor for the development of cardiovas-
cular disease.1 Experimental data also suggest that age
predisposes the vascular beds to progressive diseases. Spag-
noli et al2 demonstrated that vascular lesions were more
severe in old rabbits than in young rabbits. Similar obser-
vations have also been reported in primates.3 Furthermore,
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after arterial injury than their younger counterparts do.4
Neointimal formation is the pathologic hallmark of several
obliterative vascular diseases, including primary atheroscle-
rosis, post stent restenosis, and allograft vasculopathy. It is
generally accepted that vascular injury results in migration,
proliferation, and accumulation of vascular smooth muscle
cells (VSMCs) in the intima, creating a neointima.5 Possi-
ble phenotypic changes in VSMCs during neointimal for-
mation include increased proliferation,6-8 decreased sus-
ceptibility to apoptosis,9-11 and exaggerated extracellular
matrix deposition.12-14 Although exaggerated neointimal
formation in aging animals is well documented, the under-
lying mechanisms responsible for this phenomenon are not
clearly understood.4 If the mechanisms are to be studied in
depth, mouse models are indispensable, because knockout
and transgenic technologies are more readily available in
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development or the in vitro cellular correlates of neointimal
formation have not been studied in mice.
The purposes of this study were to investigate the effect
of aging on neointimal formation in a mouse model of
mechanical vascular injury and to examine possible mecha-
nisms responsible for the effect of aging on vascular remod-
eling.
MATERIAL AND METHODS
In vivo experiments
Animals. Female aging (18 months old) and young
adult (2 months old) C57BL/6 mice were obtained from
Jackson Laboratories. Preoperatively the mice were housed
Fig 1. Exaggerated neointima formation in injured ag
cross-sections show neointimal development in aging (lef
wire injury 4 weeks before harvest (elastica–van Giesse
assessed with morphometry in carotid arteries from aging
The entire neointimal and medial areas were recorded a
aging mice (n  6) had higher cell density than did arte
analysis.in the University of Miami animal facility and were fedstandard rodent chow ad libitum. After mechanical vascular
injury the mice were housed in individual cages. All animals
were cared for according to guidelines of the institutional
Animal Care and Use Committee.
Mechanical injury model. Mice were anesthetized
with isoflurane (IsoFlo; Abbott) inhalation. The external
carotid artery was clamped proximally and distally, and a
small arteriotomy was made between the clamps to enable
passage of a 0.36-mm guide wire (Cordis). The site of
arteriotomy in the external carotid artery was 4 mm from
the common artery. The tip of the wire was introduced
through the arteriotomy and passed proximally 5 times to
create endothelial injury. The arteriotomy was then closed
with 10-0 polypropylene sutures (Prolene; Ethicon). The
arotid arteries. A, Representative photomicrographs of
young adult (right)mouse carotid arteries subjected to
n; original magnification 40). B, Intima-media ratio
17) and young (n 6) mice in response to wire injury.
ls from digitized pictures. C, Neointimas in arteries in
n young mice (n  6), as determined at morphometricing c
t) and
n stai
(n
s pixe
ries icontralateral carotid arteries were used as control arteries.
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fixation was performed with 4% paraformaldehyde in
phosphate-buffered saline solution (PBS) at 100 mm Hg
for 15 minutes, followed by en bloc excision of arteries.
Specimens were fixed overnight in 4% paraformaldehyde in
PBS. The following day the common carotid arteries were
dissected from the specimen, and 2 segments 5 mm in
length were cut from the artery and processed for paraffin
embedding.
Assessment of neointimal proliferation. Histologic
sections 4 to 5 micrometers thick were cut from both
segments, corresponding to themidportion of each paraffin
bloc, and stained with either elastica von-Giessen (EVG) or
hematoxylin-eosin (American HistoLabs) stain. EVG en-
abled optimal delineation of the inside edge of the medial
layer as well as the neointima. Images from slides stained
with hematoxylin-eosin and with EVG were recorded with
a digital charge-coupled device video camera on an Olym-
pus BH-2 light microscope (Olympus America). Images
were processed with PhotoShop version 5.0 software
(Adobe System) color recognition, picture element dissec-
tion, and histogram determination properties. The degree
of neointimal formation was calculated as total neointimal
area to total medial area on full rings of EVG-stained
cross-section pictures.
Culture of VSMCs. Cells were harvested and cul-
tured from the thoracic aortas of young and aging adult
mice as described.15 Animals were anesthetized and exsan-
guinated, and a 1-cm length of thoracic aorta was digested
with culture medium (Dulbecco minimum essential me-
dium [DMEM] supplemented with F12 and fetal bovine
serum [FBS], 60:30:10) containing 2 mg/mL of collage-
nase for 2 hours. The tissue was then removed and cut into
1  1-mm pieces, and cultured in 6-well plates. When
confluent areas of cell growth could be seen at inverted
light microscopy, cells were trypsinized, expanded, and
frozen in liquid nitrogen for further experiments. SMCs
Differentially expressed angiogenesis-related genes in aging
Symbol Gene name G
Agpt2 Angiopoietin2 NM
Cdh5 Cadherin5 NM
Csf3 G-CSF M1
Erb2 Erb-2 U7
Fgf2 bFGF M3
Fgf4 FGF4 M3
Fgf7 FGF7/KGF U5
Fgfr3 FGFR3 M8
Fgfr4 FGFR4 NM
Igf1 IGF-1 NM
Nos3 NOS3 NM
Pdgfra PDGFRa NM
Rsn Restin NM
G-CSF, Granulocyte stimulating factor; bFGF, basic fibroblast growth facto
insulin-like growth factor; Nos3, endothelial nitric oxide synthase; PDGFRa
*Aged vs young expression ratio.
†Calculated with t test with unequal variances, and n  3.were identified at immunostaining with anti–smooth mus-cle actin monoclonal antibody clone 1A4 (Sigma). Confir-
matory Western blot analysis was also performed for anti–
smooth muscle alpha actin and heavy chain myosin
production by the cultured cells.
Microarray experiments
Using mouse angiogenesis GE array Q series (MM-
009; SuperArray), we compared aging versus young
VSMCs with respect to expression of 96 genes involved in
modulating biologic processes of angiogenesis. For these
experiments total RNA was extracted from cells with
TriReagent (MRC). Integrity of RNA was assessed with
visualization of ethidium bromide–stained gels. The mi-
croarrays were used according to the manufacturer’s in-
structions. In brief, complementary DNA was prepared
from total RNA with reverse transcription with MMLV
reverse transcriptase, radiolabeled with phosphorus 32–
deoxycytidine triphosphate; 3000 Ci/mmol/L; Amer-
sham Pharmacia Biotech), then hybridized to a positively
charged nylon membrane containing the arrayed DNA.
After washing, the arrays were visualized at autoradiogra-
phy. Gene expression was quantitated with scanning den-
sitometry. Loading was adjusted on the basis of intensity of
hybridization signals to the housekeeping genes. Each ex-
periment was performed at least twice, with 2 independent
cell lines per group, to ensure reproducibility of results.
Semiquantitative reverse transcriptase polymerase
chain reaction. Reverse transcription was performed on 2
g of total RNA with oligo(dT)15 primer and MMLV
reverse transcriptase (Roche). Primers 5=GCTATCAG-
GAGCATCCG3= (forward) and 5=CCCAAAGCGACAT-
CAG3= (reverse) were used to amplify a 407 base pair of
PDGFR-messenger RNA (mRNA). -Actin was used as a
housekeeping gene, because its expression remained stable
in the young and aging mouse VSMCs. The amplified
samples were separated on 3% agarose gel, and were ana-
lyzed with densitometry (NIH Image software). Data were
oung vascular smooth muscle cells
ank A/Y ratio* P†
621 1.407614 .014463
868 0.465647 .056745
4.756394 .007154
6.814491 .077356
3.554097 .02718
0.252636 .004399
0.281936 .028598
0.115272 .017396
011 10.20378 .00939
512 0.13024 .017362
713 8.688965 .024276
058 11.43478 .001265
765 10.66855 .000436
, fibroblast growth factor; FGFR, fibroblast growth factor receptor; IGF-1,
let-derived growth factor receptor-.vs y
ene b
_009
_009
3926
1126
0644
0642
8503
1342
_008
_010
_008
_011
_019
r; FGF
, plateexpressed as relative mRNA concentrations determined by
sent t
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mRNA.
Immunohistochemistry
Sections frommouse arteries were immunohistochemi-
cally stained for -actin (anti–smooth muscle -actin,
1:100; 1A4/M851; Dako) and PDGFR- (anti-PDGFR-
sc-338, 1:200; Santa Cruz Biotechnology). Arterial sec-
tions were deparaffinized, rinsed in xylene, and rehydrated.
Subsequently they were quenched with 3% hydrogen per-
Fig 2. Upregulation of PDGFR- gene expression in va
increases PDGFR- in VSMCs as shown on represent
polymerase chain reaction confirmation of messenger RN
lines. *P .05.C, Aging VSMCs respond more readily t
(lower panel). In contrast, aging and young VSMCs proli
2% fetal calf serum only; upper panel). Cell counts repreoxide, washed in water, treated with 2% ovine albumin inPBS, and incubated with the primary antibodies at 37°C for
2 hours. After being washed in PBS the primary antibody
was detected with biotinylated anti-mouse or anti-rabbit
immunoglobulin G for 60 minutes at room temperature.
Sections were washed in PBS, reacted with horseradish
peroxidase–conjugated streptavidin (1:5000; Dako), and
developed with 3,3=-diaminobenzidine. Negative controls
were prepared by substitution of the primary antibody with
an irrelevant antibody.
VSMC growth curves. VSMCs cultured from aortas
r smooth muscle cells (VSMCs) in aging mice. A, Aging
complementary DNA arrays. B, Reverse transcriptase
els for PDFGR- in 3 aging and young individual VSMC
GF-BB (10 ng/mL) than their younger counterparts do
at the same rate in control media (ie, supplemented with
he average of at least 3 repeated experiments.scula
ative
A lev
o PD
ferateof aging and young mice were plated into separate 24-well
action
ointim
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allowed to attach to the plates in culture medium over-
night, and the medium was then replaced with low serum
medium (DMEM supplemented with 0.1% FBS). Cells
Fig 3. Expression of PDGFR- in mouse aorta. Abun
assessed with immunohistochemical staining, in contras
positively stained cells was counted against unstained v
VSMC phenotype was ascertained with VSMC -actin
antibody was substituted with the immunoglobulin G fr
Fig 4. Vascular smooth muscle cells (VSMCs) from ag
Aging VSMCs are less susceptible to apoptosis under seru
mol/L; (B), as assessed with a Cell Death ELISA kit. Da
sample. *P  .05). Terminal deoxynucleotidyl transfe
staining (TUNEL) shows more apoptotic cells in the newere counted at time zero and every 24 hours thereafter for6 days. Growth curves were additionally established for
VSMCs cultured in DMEM supplemented with 2% FBS
and 10 ng/mL of human PDGF-BB (Invitrogen), a well-
known VSMC mitogen. Four wells were counted for each
e of PDGFR- is present in uninjured aging aortas, as
the barely stained young vessels (right panel). Percent
r smooth muscle cells (VSMCs; left panel). *P  .05.
clonal antibody. In the negative controls, the primary
of normal goat serum.
ice are less susceptible to apoptosis in vitro and in vivo.
rvation (A) than to exposure to nitric oxide (NO; at 200
re normalized for total amount of protein present in each
mediated deoxyuridine triphosphate nick-end labeled
a of young compared with aging aortas (C). *P  .01.danc
t with
ascula
monoing m
m sta
ta we
rase–time point, with a cell counter (Coulter Electronics). Each
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cell lines.
Apoptosis assays. Cells were plated in 24-well plates
at a density of 5  103 cells per well and allowed to attach
to the plates in culture medium overnight. The following
morning, apoptosis was induced with either serum starva-
tion condition (DMEM–0.1% FBS) or exposure to nitric
oxide (NO). In the serum starvation experiment the culture
media were replaced with low serum medium, and cells
were incubated for 48 hours before being assayed for
apoptosis. In the NO induced-apoptosis experiment cells
were kept in DMEM–0.1% FBS supplemented with 200
mol/L of the NO donor S-nitroso-N-acetylpenicillamine
(Sigma) for 2 hours.
Apoptosis was quantified by measuring the level of
histone-associated DNA fragments, with the Cell Death
ELISA [enzyme-linked immunosorbent assay] Kit Plus
(Roche Molecular Biochemicals). After the specified treat-
ment, medium was removed and cells were incubated in
200 L of lysis buffer for 30 minutes. Cell extracts were
spun for 15 minutes at 10,000 rpm, and 20 L of the
supernatant was transferred to a 96-well microtiter plate.
Subsequently, 80 L of the antibody mix (1 anti-histone:1
anti-DNA-horse radish peroxidase [HRP]) was added, and
the plate was incubated at room temperature for 2 hours.
Excess antibody was washed, and 100 L of substrate
solution was added. The absorbance values were deter-
mined at 405 nm with a microtiter plate reader (Bio-Rad
Labs) and normalized according to the amount of soluble
proteins determined with the Bradford method.16 In-
creased absorbance corresponds to increased apoptosis
with this technique.
In situ detection of apoptotic VSMCs in mouse
arteries. Paraffin sections of injured arteries were pre-
treated (30 minutes at 37°C) with proteinase K in 50
mmol/L of Tris hydrochloride, pH 8.0, and rinsed twice in
PBS. Terminal deoxynucleotidyl transferase–mediated de-
oxyuridine triphosphate nick-end labeled (TUNEL)–posi-
tive cells were detected with a TUNEL kit (Upstate).
Sections were incubated at 37°C for 1 hour with biotin–
deoxyuridine triphosphate in the presence of terminal de-
oxynucleotidyl transferase. Control sections were incu-
bated with biotin–deoxyuridine triphosphate in the
absence of deoxynucleotidyl transferase. The sections were
then incubated with Avidin–fluorescein isothiocyanate for
30 minutes at 37°C and mounted with Vectashield mount-
ing medium with 4,6-diamino-2-phenylindole (Vector
Laboratories). TUNEL-positive cells were detected with
fluorescent microscopy.
Matrix metalloproteinase (MMP)–2 and MMP-9
activity. Cell supernatants were collected 72 hours after
cell starvation. MMP-2 and MMP-9 activity was assessed
with 10% zymogram gels as described.17 Medium was
diluted to normalize for cell number before the addition of
5X Laemmli buffer under nonreducing conditions. After
electrophoresis, gels were washed for 1 hour in 2.5% Triton
X-100, and incubated for 40 hours in 50 mmol/L of Tris
buffer. The gels were stained with Coomassie blue, andair-dried. Densitometry, with NIH Image 1.6 software,
was used to assess relative enzyme levels.
Statistical analysis
Unless otherwise noted, quantitative data are expressed
as mean  SD. Comparisons were made wiht t tests for
independent samples with unequal variance.
RESULTS
Aging mice exhibit exaggerated neointimal devel-
opment after mechanical vascular injury. Four weeks
after injury significantly more neointima developed in the
aging (n  17) mice than in their young (n  6) counter-
parts (intima-media ratio, 1.17 0.58 vs 0.500.16; P
.001; Fig 1). Neointimal cellular density was significantly
higher in aging animals than in young animals (34.63 5.7
vs 22.34  11.13; P  .044). The contralateral uninjured
common carotid arteries showed no neointimal formation
(data not shown). Potential cellular mechanisms for these
findings were explored in the following experiments.
Angiogenesis-related genes are differentially ex-
pressed in aging and young VSMCs. The Table summa-
rizes angiogenesis-related genes differentially expressed by
aging VSMCs. Compared with young VSMCs, expression
of PDGFR- (11.43-fold; P .0012), restin (10.6-fold; P
 .000436), Nos3 (8.6-fold; P .024), Fgfr4 (10.20-fold;
P  .009), and Erb2 (6.8-fold; P  .077) were notably
increased in aging VSMCs. In contrast, expression of Fgf4
(0.25-fold; P  .0043), Fgfr3 (0.11-fold; P  .017), and
cadherin 5 (0.46-fold; P .056) were lower in aging cells.
VSMCs derived from aging mice proliferate faster
in the presence of PDGF-BB. PDGF is a well-known
VSMC mitogen that has an important role in neointimal
development after vascular injury.18,19 Because our array
data (Table) demonstrated that expression of PDGFR-
was significantly higher in aging VSMCs, we decided to
investigate the role of the PDGF/PDGFR pathway on the
proliferative responses of VSMCs from aging and young
mice. Our reverse transcriptase polymerase chain reaction
data confirmed that expression of PDGFR- was signifi-
cantly higher in the aging cells (Fig 2, A and B). Increased
expression of PDGFR- in aging VSMCs compared with
young cells was consistently seen in 3 independent cell
lines. Moreover, aging cells exhibited significantly in-
creased overall growth throughout the growth curve in the
presence of the commonly used in vitro concentration (10
ng/mL) of PDGF-BB in culture medium containing 2%
FBS (Fig 2, C). PDGF-BB activates both PDGFR- and
PDGRR-.20 Therefore aging cells exhibit increased pro-
liferation in a PDGF-enhanced environment, which is de-
signed to mimic the vascular injury microenvironment.21
Medial VSMCs in aging mouse aortas express more
PDGFR-. Guided by our in vitro data on the role of the
PDGF/PDGF pathway on aging and young VSMCs, we
next investigated the presence of PDGF-R in whole aortas.
With immunohistochemical analyses we labeled the medial
VSMCs of the injured mouse aortas with either anti-
PDGFR- or VSMC actin. Our data demonstrated that
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than their young counterparts did (Fig 3).
VSMCs from aging mice are less susceptible to
apoptosis. Resistance to apoptosis may also contribute to
the increased neointima seen in aging animals in response
to injury. To test this hypothesis we carried out a series of in
vitro and in vivo experiments. We first challenged both
aging and young mouse VSMCs to serum starvation, a
condition that induces apoptosis. After 48 hours of serum
starvation, aging cells demonstrated significantly less sus-
ceptibility to apoptosis (75% less) than did young mouse
VSMCs (Fig 4, A). We observed that NO, whose produc-
tion is enhanced at sites of vascular injury22 but not in
atherosclerotic lesions, caused dose-dependent increases in
apoptosis in mouse VSMCs (data not shown). We next
exposed aging and young VSMCs to a NO donor, S-
nitroso-N-acetyl-penicillamine. In response to NO expo-
sure, aging cells underwent less apoptosis (50% less) than
their young counterparts did (Fig 4, B). Aortic VSMCs
from aging mice exhibit greater growth capacity in serum
poor (0.1% FBS) medium than do those from young mice
(Fig 5). It is possible that, because of their reduced suscep-
tibility to apoptosis, aging VSMCs survive better in serum-
starved conditions, resulting in higher cell counts.
Finally, in agreement with our in vitro results, the
incidence of apoptosis in neointimal VSMCs, as deter-
mined with the TUNEL assay, was higher in the injured
arteries of young mice compared with those of aging mice
(8.75%  3.3 vs 2.8%  1.9; P  .021). Mean numbers of
apoptotic cells in arterial rings in each group are shown in
Fig 4, C.
Production and activation of ECM degrading en-
zymes did not differ between aging and young mice.
Fig 5. Aortic vascular smooth muscle cells from aging mice ex-
hibit greater growth potential in serum-poor (0.1% fetal bovine
serum) medium (*P  .05) than those from young mice. Growth
increment was expressed as a ratio of the number of cells at a given
time (T) and at time zero (To); see Material and methods.VSMCs from aging and young mice expressed similar levelsof MMP-2. Neither set of cells expressed substantial
MMP-9 in response to serum starvation (Fig 6).
DISCUSSION
Neointimal proliferation is well established as a major
contributor to cardiovascular and peripheral vascular dis-
eases that involve luminal obstruction. These include pri-
mary atherosclerosis, recurrent stenosis after coronary ar-
tery stenting, and allograft vasculopathy. The common
characteristic of these diseases is that initial arterial injury
ultimately results in expansion of a pathologic neointimal
layer and progressive occlusion of the vessel. The current
study examined the extent of neointimal formation in aging
and young mice with mechanical injury. Our data indicate
that aging exaggerates neointimal formation in response to
vascular injury in mice. Furthermore, we have demon-
strated that the cellular events that lead to neointimal
formation, specifically, VSMC proliferation and resistance
to apoptosis, increase in aging mice.
Aging increases neointimal formation in rats.4 In addi-
tion, injured vessels or cultured VSMCs from aging rats
exhibit increased proliferation6,23-25 and less apoptosis26
when compared with young counterparts. To our knowl-
edge, no other comprehensive reports demonstrate all of
Fig 6. No significant differences were noted between aging and
young vascular smooth muscle cells with regard to matrix metal-
loproteinase (MMP-2 andMMP-9) activity at gelatin zymography.these features of neointimal formation in a mouse model.
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model of age-related exacerbation of vascular response to
injury and previous findings in rats4 and larger animals2,3
lies in the relevance of the mouse model for understanding
the genetic and molecular mechanisms of this pathologic
phenomenon. Molecular biology tools are more readily
available for the mouse than for any other animal model.
More important, genetically manipulated mice with trans-
genic and knockout technology are readily available. This
enables specific genes to be studied in greater detail than
can be attained in experiments involving larger animals.
PDGF/PDGFR signaling has an important role in
neointimal development after arterial injury.27 Daily ad-
ministration of anti-PDGFR- antibody significantly re-
duced neointimal formation in the rat cardiac allograft
model20 and in cholesterol-fed rabbits.28Moreover, PDGF
binding sites increase in senescent VSMCs.29 Our results
reported herein further support the important role of the
PDGF/PDGFR pathway in exaggerated neointimal devel-
opment associated with aging. We demonstrate both in
vitro and in vivo that aging VSMCs express more
PDGFR- than young cells do (Fig 2, A and B, and Fig 3).
We also show that VSMCs from aging mice have an in-
creased proliferative response to PDGF-BB (Fig 2, C),
which is able to activate both PDGF receptors.27 Collec-
tively, our findings, along with those of others, suggest an
important role for the PDGF/PDGFR pathway in the
exaggerated neointimal formation associated with aging.
Of note, our data do not demonstrate age-related
differences in either MMP-2 or MMP-9 in mouse VSMC
cultures. Increased MMP-2 activity has been demonstrated
in the neointima of rats and rabbits after vascular inju-
ry.30-32However, published data on age-related differences
in MMP-2 activity are contradictory, showing both in-
creased and decreased levels in aging neointimal tissue.31,33
We believe that such discrepancies are due more to condi-
tions of culture than to the model itself. Previous in vitro
studies have not addressed the production of MMP-2 and
the other extracellular matrix proteins in cultured VSMCs.
In conclusion, our results indicate that aging exagger-
ates vascular response to injury in mice. We show that aging
increases the ability of VSMCs to proliferate and decreases
their susceptibility to undergo apoptosis. We also demon-
strate the important role of the PDGF/PDGFR pathway in
the exaggerated neointimal formation associated with ag-
ing. Understanding the mechanisms responsible for this
phenomenon may facilitate prevention or provide new
therapies for vascular occlusive diseases. Our ability to
reproduce the model in the mouse will no doubt facilitate
such understanding.
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E. J. Wylie Memorial Traveling Fellowship 
Application Deadline: January 14, 2005 
he E. J. Wylie Memorial Traveling Fellowship provides the recipient with the opportunity to visit a number of 
xcellent vascular surgery centers in the United States and abroad.  These visits stimulate academic inspiration, 
romote international exchange, and foster development of fraternal fellowship in vascular surgery, which enhance 
e development of the fellow's career in vascular surgery. The Lifeline Programs of the American Vascular 
ssociation will award $12,000 for travel, research & clerical expenses to the 2005 E.J. Wylie Traveling Fellow. 
ligible candidates should be under age 40 at the time of the award and have completed a postgraduate vascular 
aining program or have considerable experience in vascular surgery supplemental to surgical training.  Candidates 
hould be committed to an academic career in vascular surgery and have obtained an academic appointment in a 
edical school or freestanding clinic devoted to excellence in medical education.  Candidates should also have a 
emonstrated record of success in pursuing clinical or basic science research sufficient to ensure academic 
xcellence in his or her pursuit of a career in vascular surgery. 
he application deadline is January 14, 2005.  For more information on the application procedures, contact the 
ifeline Programs at lifeline@vascularsociety.org or visit VascularWeb (http://www.vascularweb.org/).   
